Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axogen (AXGN) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Axogen (AXGN) over the last 16 years, with Q3 2025 value amounting to $23.9 million.

  • Axogen's Cash & Equivalents rose 2807.84% to $23.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.9 million, marking a year-over-year increase of 2807.84%. This contributed to the annual value of $27.6 million for FY2024, which is 1118.49% down from last year.
  • Latest data reveals that Axogen reported Cash & Equivalents of $23.9 million as of Q3 2025, which was up 2807.84% from $20.0 million recorded in Q2 2025.
  • Axogen's Cash & Equivalents' 5-year high stood at $53.1 million during Q2 2021, with a 5-year trough of $7.7 million in Q1 2023.
  • Its 5-year average for Cash & Equivalents is $24.5 million, with a median of $20.0 million in 2025.
  • Per our database at Business Quant, Axogen's Cash & Equivalents tumbled by 7772.71% in 2022 and then soared by 11716.72% in 2023.
  • Over the past 5 years, Axogen's Cash & Equivalents (Quarter) stood at $32.8 million in 2021, then plummeted by 53.34% to $15.3 million in 2022, then surged by 102.98% to $31.0 million in 2023, then fell by 11.18% to $27.6 million in 2024, then fell by 13.25% to $23.9 million in 2025.
  • Its Cash & Equivalents stands at $23.9 million for Q3 2025, versus $20.0 million for Q2 2025 and $18.1 million for Q1 2025.